Hepatitis - AASLD - Liver Conference - HCV - HepC - HBV - HepB
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:
HIGHLIGHTS
What you need to know
> Blogs > Hep Exclusives > Hepatitis News > Lessons


Hepatitis C Surpasses HIV as Cause of Death in U.S.

It’s official. Chronic hepatitis C virus infection is associated with more deaths than HIV infection.



100% Hep C Genotype 2/3 Cure

Promising results for interferon-free PSI-7977 regimen.



Targeting
Hep C

Gene-targeting therapy shows promise against hepatitis C.


The Liver Meeting 2011

Latest from the American Association For the Study of Liver Diseases (AASLD).



Combo Shines In Treating HCV

24-week experimental combo cured 91 percent of people with genotype 1 hep C.



HIV/HCV Treatment Options Coming

Incivek and Victrelis working well in coinfection studies.


Baby Boomers and Hep C

Testing individuals born between 1945 and 1965 would help identify more than 800,000 people living with hep C.



Combo Hep B Treatment Shows Limited Benefit

Baraclude/Viread generally no better than Baraclude alone.



Hep C Pipeline Update From AASLD

Join the conversation in the Hep Forums.

NEWSFEED
AASLD Coverage

Hep C Protease Inhibitors May Not Be Cost-Effective For Some First-Time Treatment Takers

BMS Oral Hep C Drug Combo Cures 90% of Null Responders With Genotype 1b in Japanese Study

Blood Thinner Reduces Liver Vein Blood Clots, Protects Liver Functioning in People With Cirrhosis

Interferon-Free Protease/Polymerase Inhibitor Combo Showing Well in Hep C Genotype 1 Study

Milk Thistle Extract Comparable to Placebo in Hep C Liver Enzyme Study

Interferon-Free Alisporivir Treatment Showing Promise in Genotype 2/3 Trial

TMC435, Peg-Interferon and Ribavirin Combo Boosts Cure Rates for Hep C Genotype 1

Five-Year Viread Follow-Up: Long-Term Hep B Suppression, Plus Fibrosis and Cirrhosis Improvements

Hepatitis C Surpasses HIV as Cause of Death in U.S.

Testing All Baby Boomers for Hep C Would Find 86% of Infections, Say Researchers

Incivek, Victrelis Working Well in HIV/HCV Coinfection Studies

Gene-Targeting Therapy Shows Promise Against Hepatitis C

PSI-7977, Peg-Interferon, Ribavirin Combo Shines in Genotype 1 Hep C Study

Adding Viread to Baraclude for Hep B Treatment Shows Limited Benefit

Twelve Weeks Interferon-Free PSI-7977 Regimen Cures 100 Percent Hep C Genotype 2/3

HEP TV
Footage from the front lines
Andrew Muir, MD, MHS, chief of the Duke Division of Gastroenterology, on first visiting a liver specialist.
> More Hep TV
TALK TO US
Tell us what you think
Poll
Should Medicaid limit access to new hep C drugs?
Yes
No


Survey
Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.